Atlas Trials

COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease

Clinical trial NCT05998824 · COMPLETED

Trial details

NCT number
NCT05998824
Sponsor
Duke University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Sickle Cell DiseaseCOVID-19 VaccineVaccine Hesitancy
Start date
2023-09-19
Primary completion
2024-09-30
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.